We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GCI
601
DELISTED
Gannett Co., Inc
GCI
| $5.68M | 0.02% |
530,500
+408,300
| +334% | +$4.22M |
|
602
Sinclair Inc
SBGI
$1.02B
| $5.67M | 0.02% |
176,200
+100,100
| +132% | +$3M |
|
603
Radian Group
RDN
$4.68B
| $5.64M | 0.02% |
347,800
-23,500
| -6% | -$384K |
|
|
WEB
604
DELISTED
Web.com Group, Inc.
WEB
| $5.61M | 0.02% |
216,900
-17,900
| -8% | -$360K |
|
|
GGP
605
DELISTED
GGP Inc.
GGP
| $5.58M | 0.02% |
273,326
-199,183
| -42% | -$4.04M |
|
606
KLA
KLAC
$220B
| $5.57M | 0.02% |
543,430
-1,290
| -0.2% | -$14K |
|
|
OBSV
607
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $5.56M | 0.02% |
+367,500
| New | +$4.88M |
|
608
FTI Consulting
FCN
$4.06B
| $5.55M | 0.02% |
91,700
-102,800
| -53% | -$5.96M |
|
609
United Natural Foods
UNFI
$2.7B
| $5.51M | 0.02% |
+129,200
| New | +$5.7M |
|
610
Core Laboratories
CLB
$563M
| $5.51M | 0.02% |
43,657
+8,396
| +24% | +$1.02M |
|
611
Assembly Biosciences
ASMB
$532M
| $5.46M | 0.02% |
11,605
+1,860
| +19% | +$984K |
|
612
Icon
ICLR
$13.3B
| $5.46M | 0.02% |
41,192
+8,001
| +24% | +$997K |
|
613
Fox Factory Holding Corp
FOXF
$805M
| $5.43M | 0.02% |
116,730
+50,918
| +77% | +$1.97M |
|
|
ELGX
614
DELISTED
Endologix Inc
ELGX
| $5.43M | 0.02% |
95,984
-295
| -0.3% | -$15K |
|
615
Citizens Financial Group
CFG
$29.6B
| $5.42M | 0.02% |
139,177
-10,921
| -7% | -$455K |
|
616
Crocs
CROX
$5.34B
| $5.41M | 0.02% |
+307,300
| New | +$5.23M |
|
617
ICICI Bank
IBN
$102B
| $5.32M | 0.02% |
662,036
| – | – |
|
|
WBT
618
DELISTED
Welbilt, Inc.
WBT
| $5.24M | 0.02% |
234,952
+76,718
| +48% | +$1.53M |
|
|
MLNX
619
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $5.23M | 0.02% |
62,000
| – | – |
|
620
iShares Russell Mid-Cap Growth ETF
IWP
$19B
| $5.21M | 0.02% |
82,308
| – | – |
|
621
A.O. Smith
AOS
$7.78B
| $5.21M | 0.02% |
88,043
+10,549
| +14% | +$665K |
|
|
ONCE
622
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $5.21M | 0.02% |
62,915
-37,085
| -37% | -$2.86M |
|
623
Progress Software
PRGS
$1.79B
| $5.12M | 0.02% |
132,000
+98,500
| +294% | +$3.74M |
|
624
Acadia Realty Trust
AKR
$2.7B
| $5.11M | 0.02% |
186,809
+23,687
| +15% | +$595K |
|
625
Newmont
NEM
$131B
| $5.11M | 0.02% |
135,471
-5,113
| -4% | -$201K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.